Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00330798 · ClinicalTrials.gov registry record · Phase 4
A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief
A Phase 4 study of Photorefractive Keratectomy, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT00330798: Completed Phase 4 study of Photorefractive Keratectomy, sponsored by Alcon Research.
NCT00330798 is a Phase 4 study of Photorefractive Keratectomy that has completed, run by Alcon Research. The registered enrollment target is 40 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00330798, a Phase 4 study of Photorefractive Keratectomy, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare healing times and subjective pain level responses of nepafenac to placebo after photo refractive keratomileusis (PRK) surgery.
Conditions Studied
Interventions
- DRUG nepafenac 0.1%
- OTHER ketorolac 0.4%
Study Locations (1)
Texas
- Lackland Air Force Base - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2006-02 |
| Est. Completion | 2006-06 |
| Phase | Phase 4 |
What the finished NCT00330798 record still lists
NCT00330798 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Photorefractive Keratectomy appearing as the primary indexed condition, and to 2 interventions - of which nepafenac 0.1% is the first listed.
NCT00330798 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00330798 about?
NCT00330798 is a clinical study titled "A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief". The purpose of this study is to compare healing times and subjective pain level responses of nepafenac to placebo after photo refractive keratomileusis (PRK) surgery.
What is the current status of trial NCT00330798?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2006-02. Estimated completion is 2006-06.
What conditions does trial NCT00330798 study?
This clinical trial studies the following conditions: Photorefractive Keratectomy.
What interventions are being tested in trial NCT00330798?
The interventions under investigation include: nepafenac 0.1% (DRUG), ketorolac 0.4% (OTHER).
Who is sponsoring clinical trial NCT00330798?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00330798 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Photorefractive Keratectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00330798's enrollment target sits among peer trials
40 1397th of 2000 higher than 533 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia